New technology serves as reminder for the appropriate uses of CRISPR.
Anne Elise Herold Li
Advertisement
Partner in Crowell & Moring's Life Sciences Litigation, Intellectual Property, and Trade Secrets groups in New York
Articles by Anne Elise Herold Li
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
3
Novavax's Strategy Across Commercial, R&D, and Partnerships
4
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
5